Papel da imagem na estratificac ão de risco e na predic ão do risco tromboemboĺico

Similar documents
ACUTE CENTRAL PERIFERALEMBOLISM

Thromboembolism During Sinus Rhythm in Patients with a History of Atrial Fibrillation

Controversies in Risk Stratification

Risk Stratification for Stroke Prevention in Patients with Atrial Fibrillation: The emerging role of biomarkers

Left Atrial Appendage Closure: The Rationale

Prognostic Value of Left Atrial Size and Function

Atrial fibrillation and advanced age

Cleveland Clinic Policy

Controversies in Risk Stratification

Left atrial Function In Echocardiography

Page 1. Current Trends in the Management of Atrial Fibrillation: Left Atrial Appendage Occlusion. Atrial fibrillation: Scope of the problem

ROUVIERE Héloïse, DE MEESTER Antoine, DESCAMPS Olivier, NICAISE Grégory, MARCOVITCH Olivier,BADOT Damien, TUTUS Caroline, BENAHMED Ahmed

심방세동과최신항응고요법 RACE II AFFIRM 항응고치료는왜중요한가? Rhythm control. Rate control. Anticoagulation 남기병 서울아산병원내과. Clinical Impact of Atrial Fibrillation

Manuel Castellá Cardiovascular Surgery Hospital Clínic, Universidad de

A Large prolapsing left Atrial Appendage Thrombus in Sinus Rhythm

Peri-cardioversion and peri-ablation anticoagulation. Giuseppe Patti Campus Bio-Medico University of Rome

EAE RECOMMENDATIONS FOR TRANSESOPHAGEAL ECHO. Cardiac Sources of Embolism. Luigi P. Badano, MD, FESC

Devices to Protect Against Stroke in Atrial Fibrillation

Should AF patients (after ablation) have anticoagulation forever? Can we ever stop it?

Atrial Fibrillation and the NOAC s. John Raymond MS, PA-C, MHP February 10, 2018

Patients selection criteria for LAA occlusion. Young Keun On, MD, PhD, FHRS Samsung Medical Center Sungkyunkwan University School of Medicine

Left Atrial Appendage Occlusion

ROLE OF IMAGING IN ARRHYTHMIA/DEVICES I ATRIAL FΙBRILLATION: CLINICAL TYPES AND OUTCOME (PROGNOSIS)

SUPPLEMENTARY INFORMATION

Role of cardiac imaging for catheterbased left atrial appendage closure

OAC after apparently successfull AF ablation: when, why, and how?

C. Jilek, S. Fichtner, H. L. Estner, T. Reents, S. Ammar, J. Wu, T. Meyer, E. Hendrich, C. Kolb, J. Hausleiter, G. Hessling, I.

Post-ablation Management: Drug therapy, Anticoagulation and long-term Monitoring

Mohammad Zubaid, MB, ChB, FRCPC, FACC

Arrhythmia 341. Ahmad Hersi Professor of Cardiology KSU

Bogdan A. Popescu. University of Medicine and Pharmacy Bucharest, Romania. EAE Course, Bucharest, April 2010

1 INTRODUCTION ORIGINAL INVESTIGATION

Congenital Absence of the Left Atrial Appendage Visualized by 3D Echocardiography in Two Adult Patients

Progression of atrial fibrillation: can we prevent it? Early catheter ablation will stop progression of atrial fibrillation pro

Modern aspects in multidisciplinary thromboembolic prophylaxis. AMPLATZER Left Atrial Appendage data update

Basics of Atrial Fibrillation. By Mini Thannikal NP-BC Mount Sinai St Luke s Hospital New York, NY

Exclusion de l auricule gauche par voie percutanée

Does the left atrial appendage morphology correlates with the risk of stroke in patients with atrial fibrillation? Result from a multicenter study.

Invasive and Medical Treatments for Atrial Fibrillation. Thomas J Dresing, MD Section of Electrophysiology and Pacing Cleveland Clinic

Left Atrial Appendage Occlusion in the Era of Novel Anticoagulants

Updates in Atrial Fibrillation

Ruolo della ablazione della fibrillazione atriale nello scompenso cardiaco

Stroke Prevention in AF: How will it change in the next 5 years? Jeff Healey MD, MSc, FHRS Population Health Research Institute McMaster University

The Emerging Atrial Fibrillation Epidemic: Treat It, Leave It or Burn It. Chandra Kumbar MD FACC FHRS The Heart Group, Evansville IN

Controversies in Atrial Fibrillation and HF

Primary Care Atrial Fibrillation Update: Anticoagulation and Left Atrial Appendage Occlusion. Greg Francisco, MD, FACC

Left Atrial Appendage Closure Devices. Atrial Fibrillation 10/11/2017

Treating Atrial Fibrillation. Richard Schilling. St Bartholomew's Hospital, Queen Mary s University of London

Transient Atrial Fibrillation and Risk of Stroke after Acute Myocardial Infarction

Role of LAA isolation in AF cure

Watchman Implantation Case Presentation and Discussion

What the general cardiologist should know about arrhythmia Stroke prevention in AF" Peter Ammann Kantonsspital St. Gallen

Echocardiography for the Electrophysiologist: Day-to-day practice. Emmanuel Fares, MD

ANTICOAGULANTI Trattamento interventistico GIANLUCA BOTTO FESC, FEHRA, FAIAC UO ELETTROFISIOLOGIA

Current Guideline for AF Treatment. Young Keun On, MD, PhD, FHRS Samsung Medical Center Sungkyunkwan University School of Medicine

DECLARATION OF CONFLICT OF INTEREST

Νεότερα ςτην Υπερηχοκαρδιογραφία. Βαςίλειοσ Καμπερίδησ Clinical research fellow in Cardiology

Coagulation and ischaemic stroke

Advanced imaging of the left atrium - strain, CT, 3D, MRI -

Causal relationship between AF & stroke

AF :RHYTHM CONTROL BY DR-MOHAMMED SALAH ASSISSTANT LECTURER CARDIOLOGY DEPARTMENT

ATRIAL FIBRILLATION 2018: AN UPDATE ON RECENT DEVELOPMENTS IN DIAGNOSIS AND MANAGEMENT PANOS E. VARDAS, MD, PhD

Management of Patients with Atrial Fibrillation Undergoing Coronary Artery Stenting 경북대의전원내과조용근

Case Report Pulmonary Vein Compression After Implantation of a Left Atrial Appendage Occluder: Presentation and Discussion of a Case

קוים מנחים לפרפור פרוזדורים - עדכון משה סויסה מרכז רפואי קפלן

MMS/Mass Coalition Program, Nov. 4, 2008 Patients with AF: Who Should be on Warfarin?

Management of ATRIAL FIBRILLATION. in general practice. 22 BPJ Issue 39

Management of Atrial Fibrillation in the Hospitalized Patient

Απεικονιστικές τεχνικές στην σύγκλειση του ωτίου του αριστερού κόλπου. Κ. Αγγέλη Α Πανεπιστημιακή Καρδιολογική Κλινική Ιπποκράτειο Νοσοκομείο

Atrial Fibrillation Management in the ED. J Fisher May 2014"

Interventional solutions for atrial fibrillation in patients with heart failure

Left Atrial Appendage Closure: Techniques and Guidelines. Mohammad Shenasa, MD Heart & Rhythm Medical Group San Jose, CA

Time Course for Resolution of Left Atrial Appendage Stunning After Catheter Ablation of Chronic Atrial Flutter

8/16/2016. Disclosures. Is Uninterrupted OAC Standard of Care for AF Ablation? CHRS 2016, San Francisco. Risk of Stroke Peri-Ablation

Atrial Cardiomyopathy is it relevant?

Cryptogenic Stroke: The role of silent Atrial Fibrillation

Gauging stroke risk across the AF spectrum and selecting the appropriate patient for LAA closure. Miguel Valderrábano, MD

THINK OUTSIDE THE PILLBOX

Special Conditions of NOAC PCI 가톨릭의대 순환기내과 장성원

Η ηχωκαρδιολογία στην διάγνωση κα πρόγνωση της καρδιακής ανεπάρκειας µε µειωµένο και φυσιολογικό κλάσµα εξώθησης

LA Function analysis Marcia Barbosa Vice Presidente - Brazilian Soc of Cardiology President-elect - Interamerican Soc of Cardiology

SHARED DECISION MAKING: AN EVIDENCE-BASED CORNERSTONE OF LAAC THERAPY

Atrial Fibrillaiton and Heart Failure: Anticoagulation therapy in all cases?

Atrial Fibrillation and Heart Failure: A Cause or a Consequence

Understanding Atrial Fibrillation Management. Roy Lin, MD

Association between Morphodynamic Variables by Transesophageal Echocardiography and CHA 2 DS 2. -Vasc Values ORIGINAL ARTICLE. Abstract.

Fibrillazione atriale e scompenso: come interrompere il circolo vizioso.

Is cardioversion old hat? What is new in interventional treatment of AF symptoms?

Dipen Shah Cardiology Service, University Hospitals, Geneva Switzerland

Novel Therapies for Atrial Fibrillation. Murali Chiravuri M.D., Ph.D. Cardiac Specialists Bridgeport Hospital/Yale New Haven Danbury Hospital

Intracardiac Devices for Stroke Prevention: The Heart Brain Team

Left Atrial Appendage Closure for Atrial Fibrillation 2015 UPDATE

Glenmark Cardiac Centre Mumbai, India

LAA Occluders: The Right Device for the Right Patient ACC/SHA MEETING OCTOBER 31 ST 2015 JEDDAH, KSA OMER A. M. ELAMIN, MD, FACC

The value of diastolic function parameters in the prediction of left atrial appendage thrombus in patients with nonvalvular atrial fibrillation

LEFT ATRIAL APPENDAGE CLOSURE INSTEAD OF ANTICOAGULATION; INDICATIONS AND OUTCOMES. Sheetal Chandhok, MD

Direct Oral Anticoagulant Use in Valvular Atrial Fibrillation

Stroke Update. Claire J. Creutzfeldt, MD January 12, 2018

Rebuttal. Jerónimo Farré MD 2010

ANTI-THROMBOTIC THERAPY in NON-VALVULAR ATRIAL FIBRILLATION

Transcription:

Imagiologia na Fibrilhac ão Auricular Papel da imagem na estratificac ão de risco e na predic ão do risco tromboemboĺico Mª João Andrade

Diagnosis and timely detection of atrial fibrillation Echo-machines uses a single-lead ECG Tool for screening

LAA thrombus TTE & Sinus Rhythm

Imaging-based prognostic parameters in patients with AF Bax JJ, et al. Heart 2014;0:1 7

Echocardiography in newly diagnosed atrial fibrillation patients: A systematic review and economic evaluation Conclusions When CHADS 2 was used, the addition of TTE in identifying patients with left atrial abnormality was cost-effective for informing some OAC decisions. The number of QALYs required for TTE to be cost-effective is small, and that if benefits beyond those associated with a reduction in stroke are believed probable then TTE is likely to be cost-effective in all scenarios. Our findings suggest that further research would be useful, following up newly diagnosed patients with AF who have undergone TTE, to study treatments given as a result of TTE diagnoses and subsequent cardiovascular events. This could identify additional benefits of routine testing, beyond stroke prevention. Studies assessing the proportion of people with a CHADS 2 score of 0 or 1 that have left atrial abnormality would provide better estimates of the cost-effectiveness of TTE, and allow more accurate estimates of the sensitivity and specificity of TTE for identifying left atrial abnormality in AF to be obtained Health Technology Assessment School of Health and Related Research (ScHARR), University of Sheffield, Sheffield, United Kingdom Volume 17, Issue 36, 2013, Pages 1-263

Bax JJ, et al. Heart 2014;0:1 7

AF, ATRIAL THROMBI AND STROKE Atrial fibrillation increases stroke rate by five times Over 80% of these embolic strokes are from clots originating in the left atrial appendage The Left Atrial Appendage: our Most Lethal Human Attachment! Johnson WD et al. Eur J Cardiothorac Surg. 2000

Spontaneous Echo-Contrast and Thrombi The 2 strongest predictors of cardioembolic stroke Represent an advanced grade of prothromboticstate Recorded by TEE and only rarely by TTE

Function of LAA LAA EMPTYING PEAK VELOCITIES High flow profile SR Low flow profile AF LAA peak velocity = 52 cm/s LAA peak velocity = 18 cm/s Risk stratification Independent of the basic rhythm Handke et al, JASE 2005, 18; 1366

861 consecutive patients before AF ablation CTA and TEE same day single hospital (2006 2013) Excellent NPV of CTA in assessment of LAA stasis and thrombus Positive predictive value of only 13% Possible to eliminate TEE in up to 80% of AF ablation patients based on negative CTA findings Wan, L et al. PACE 2016; 39:1388 93

Morphology of LAA Cactus Chicken Wing WindsocK Cauliflower Lupercio F et al. Heart Rhythm 2016 Anselmino M et al. Cardiovasc Med 2016, 17:169 176l.

CxAoP: an important risk factor for non-ce stroke and thromboembolism in NVAF Patients with CxAoP have different characteristics Older age Higher prevalence of hypertension Smoking history Paroxysmal AF with a smaller LA size

981 pts TEE for pre-af ablation the CHA2DS2VASc score was underestimated in 3.6% of intermediate-risk patients and 11.3% of high-risk patients before evaluating for CxAoP by TEE P.-S. Yang, et al. Int J Cardiol 2016

Risk Stratification in AF

140,420 patients with AF in Swedish nationwide health registries J Am Coll Cardiol 2015;65:225 32

266 pts TTE immediately before clinically indicated TOE Prevalence of LAA thrombus based on e and E/e ratio LAA thrombus=17 (6.4%) Doukky R et al. JASE 2016

TTE TOE Doukky R et al. JASE 2016

Incremental predictive value of diastolic function parameters beyond CHA2DS2-VASc score Doukky R et al. JASE 2016

Diagnosis of LAA thrombus E/e vs CHA 2 DS 2 -VASc score E/e vs lateral e velocity Doukky R et al. JASE 2016

171 neurologically asymptomatic pts with non-valvular AF TTE: diastolic TDI parameters TOE: LA thrombus, SEC, LAA emptying veloc, complex arch plaques Brain MRI: SBI Ishikawa S et al. Eur Heart J Card Imaging 2016

Ishikawa S et al. Eur Heart J Card Imaging 2016

Prevalences of SBI according the E/e ratio LA abnormalities and LAA emptying velocity (TOE) according to E/e ratio (TTE) Ishikawa S et al. Eur Heart J Card Imaging 2016

160 pts non-rheumatic PAF, 52 with a history stroke/tia Bayar,N et al. Anatol J Cardiol 2016; 16: 572-8

Bayar,N et al. Anatol J Cardiol 2016; 16: 572-8

Bayar,N et al. Anatol J Cardiol 2016; 16: 572-8

Incremental Value of LA Global Longitudinal Strain for Prediction of Post Stroke AF in Patients with Acute Ischemic Stroke 227 pts with acute ischemic stroke without a history of AF TTE with speckle tracking imaging for global LA longitudinal strain (LALS) Kim et al. J Cardiovasc Ultrasound 2016;24(1):20-27

CONCLUSION TTE is recommended in all AF patients to guide treatment decisions. TTE should be used to identify structural disease and assess LV size and function, atrial size, and right heart function. Cardiovascular imaging, allowing directly visualization of those alterations which may lead to the formation of intracardiacthrombi, offers itself as a unique tool helping to refine thromboembolic risk stratification. While the role of TTE is pivotal in the risk stratification of patients with AF, the use of TEE or MDCT and MRI is commonly restricted to patients with additional cardiovascular risk factors (ie, prior stroke) or undergoing specific therapies (electrical cardioversion or catheter ablation). Diastolic function assessment and LA strain evaluation may improve risk stratification and in predicting thromboembolic risk in patients with NVAF